Investment Counsel Company of Nevada’s CME Group CME Stock Holding History

Investment Counsel Company of Nevada’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3	Closed	-$887	–	170
2026 Q1	$887	Buy	+3	New	+$891	﹤0.01%	95

Other funds holding CME

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Investment Counsel Company of Nevada's CME Position: Q2 2026 in Review

Investment Counsel Company of Nevada sold out of CME Group (CME) in Q2 2026, closing a stake of 3 shares — an estimated $887 sold.

Investment Counsel Company of Nevada first reported a position in CME in Q1 2026 and held it in 1 quarter. The position peaked at $887 in Q1 2026. 1,710 funds tracked by Wall St. Rank hold CME as of Q2 2026.

Investment Counsel Company of Nevada reported no remaining CME Group position as of Q2 2026 after selling out during the quarter.
Investment Counsel Company of Nevada sold 3 CME Group shares in Q2 2026, an estimated $887.
Investment Counsel Company of Nevada first reported a position in CME Group in Q1 2026 and held it in 1 quarter.
Investment Counsel Company of Nevada's CME Group position peaked at $887 in Q1 2026.
1,710 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Investment Counsel Company of Nevada's 13F filing for Q2 2026, filed 10 Aug 2026.